权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Phospholipid-Mediated Metabolic Control in the Pathogenesis of NAFLD

NAFLD 发病机制中磷脂介导的代谢控制

基本信息

批准号：
10589147
负责人：
DAVID E. COHEN
金额：
$ 49.51万
依托单位：
BRIGHAM AND WOMEN'S HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-12-23 至 2025-03-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10589147
关键词：
Acyl Coenzyme A Address Binding Binding Proteins Biological Models Carbon Cells Characteristics CoASH Data Disease Elements Enzymes Esterification Esters Event Fasting Fatty Acids Fatty Liver Fatty acid glycerol esters Glean Glucose Glycerol Goals Grant Head Health Hepatic Hepatocyte High Fat Diet Homeostasis In Vitro Inflammation Insulin Resistance Intake Intervention Intracellular Membranes Lecithin Length Light Link Lipids Liver Mediating Medication Management Membrane Membrane Fluidity Metabolic Metabolic Control Metabolic Pathway Metabolism Mission Mitochondria Molecular Molecular Conformation Mus Muscle Fibers Mutation Analysis National Institute of Diabetes and Digestive and Kidney Diseases Nonesterified Fatty Acids Nutrient Nutritional Obesity Outcome Study Overnutrition Pathogenesis Pathogenicity Pathway interactions Phospholipids Phosphorylcholine Physiological Proteins Public Health Regulation Research Research Proposals Resistance Saturated Fatty Acids Skeletal Muscle Specificity Stress Testing Therapeutic Tissues Translating Variant biophysical techniques blood glucose regulation design endoplasmic reticulum stress experimental study extracellular vesicles fatty acid metabolism fatty acid oxidation feeding glucose metabolism insight insulin sensitivity insulin signaling lipid metabolism member mouse model muscle metabolism new therapeutic target non-alcoholic fatty liver disease novel nutrient metabolism pharmacologic phosphatidylcholine transfer protein protein function response sensor skeletal muscle metabolism small molecule small molecule inhibitor vesicular release

项目摘要

PROJECT SUMMARY/ABSTRACT Altered regulation of lipid and glucose homeostasis, most often in the setting of insulin resistance and obesity, is central to the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Because current management options remain limited, the discovery of new metabolic pathways will serve to identify novel opportunities for pharmacologic intervention. This research proposal addresses the unanswered question of whether membrane phospholipids regulate nutrient homeostasis. Our long-term goal is to understand how phospholipid-mediated metabolic control can be leveraged for therapeutic purposes. The objective of this research is to determine the molecular mechanisms whereby sensing of membrane phosphatidylcholines by phosphatidylcholine transfer protein (PC-TP) is translated into metabolic control by thioesterase superfamily member 2 (Them2), a mitochondria-associated long chain acyl-CoA thioesterase. The central hypothesis is that key regulatory events occur in the skeletal muscle when PC-TP binds specific membrane phosphatidylcholine molecular species and then activates Them2. The rationale is that regulation of skeletal muscle metabolism by Them2 should yield new insights into hepatic insulin resistance and steatosis. Guided by extensive preliminary data, the central hypothesis will be tested in three specific aims: 1) To demonstrate that Them2 controls lipid and glucose metabolism in skeletal muscle; 2) To define mechanisms whereby Them2 in skeletal muscle promotes hepatic steatosis; and 3) To elucidate the molecular determinants of Them2 activity and regulation by PC-TP. In Aim 1, mouse models will be used to determine mechanisms whereby Them2 regulates fatty acid and glucose metabolism in skeletal muscle and promotes insulin resistance in response to overnutrition. Cell autonomous functions of Them2 will be gleaned from systematic studies in cultured myotubes. Aim 2 will establish the mechanisms in high fat fed mice whereby Them2 in skeletal muscle promotes hepatic insulin resistance and steatosis. Cultured hepatocytes will be used to determine whether Them2-dependent myokines or extracellular vesicles released from myotubes control hepatic lipid and glucose metabolism. Aim 3 will determine structural characteristics that enable Them2 to respond to changes in membrane phosphatidylcholine composition. Small molecules designed to bind and inhibit Them2 will be used as probes to characterize Them2 function and interactions with PC-TP using an array of biophysical techniques. Phosphatidylcholine-dependent conformational changes in PC-TP will be leveraged to identify specific motifs that are critical for Them2 activity and stability. The interacting domains of Them2 and PC-TP will be identified and confirmed by mutational analyses. Overall, this proposal will elucidate new mechanisms of phospholipid-mediated metabolic regulation that control hepatic nutrient metabolism, which is significant because the fatty acyl composition of membrane phosphatidylcholines varies in health and disease. These studies are expected to establish Them2 as a tractable target for the management of NAFLD.

项目总结/文摘